230,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Gebundenes Buch

This book considers the pharmaceutical potential of trees of the genera commonly known as Acacia, and their potential benefits in modern healthcare. It looks at the plants' ethnomedical uses, their chemistry, and the pharmacology of principal components and pharmaceutical potential.

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book considers the pharmaceutical potential of trees of the genera commonly known as Acacia, and their potential benefits in modern healthcare. It looks at the plants' ethnomedical uses, their chemistry, and the pharmacology of principal components and pharmaceutical potential.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Ephraim Lansky holds an M.D. from the University of Pennsylvania Perelman School of Medicine and a Ph.D. in Pharmacognosy from Leiden University. He is licensed in Israel as both a physician and hypnotherapist, and currently, during the pandemic, practices classical homeopathy and Hypnoidal Suggestive Therapy remotely with patients worldwide over Zoom. Dr. Lansky is a well-known expert in the field of Medical Punicology, the use of pomegranate fruit, Punica granatum, for cosmeceutical and medical treatments, and is co-author of three books by CRC on the genera Ficus, Capparis, and Peganum. He has authored or co-authored over 35 scientific papers and is a Research Fellow at the University of Haifa in the Institute of Evolution, an interdisciplinary biological think tank and research center. He is also Series Editor for CRC's two series on medicinal plants, Medicinal and Aromatic Plants: Industrial Profiles and Traditional Herbal Medicines for Modern Times... both inaugurated and established by Dr. Roland Hardman. Dr. Lansky welcomes book proposals for either of these series from potential authors. He can be reached by email at punisyn@gmail.com. Shifra Lansky holds a PhD in chemistry from the Hebrew University of Jerusalem in Israel, and is currently working as a postdoctoral fellow at Weill Cornell Medicine in New York, USA. Her research focuses on studying the structure and dynamics of various membrane proteins. Shifra coauthored with Ephraim Lansky and Helena Paavilainen the books Caper: The Genus Capparis and Harmal: The Genus Peganum (CRC Press), and has additionally published 19 peer-reviewed articles in different international scientific journals. Helena Paavilainen is a researcher at the Hadassah Medical School, Hebrew University of Jerusalem, Israel. Her main research interests are ethnomedicine, historical ethnopharmacology, and the history of pharmacology, especially the Hebrew, Arabic, and Latin traditions. She wrote her PhD thesis (published as Medieval Pharmacotherapy: Continuity and Change; Case Studies from Ibn Sina and Some of His Late Medieval Commentators, Leiden: Brill, 2009) on the development of medical drug therapy in medieval times and on the potential validity of medieval herbal treatments. She also coauthored with Dr. Lansky the monograph Figs: The Genus Ficus (Boca Raton, FL: CRC Press, 2010), and with Dr. Lansky and Shifra Lansky the sequels Caper: The Genus Capparis (2014) and Harmal: The Genus Peganum (2017). On the historical side, she has written a series of articles on the therapeutic choices of medieval physicians, for example, "Therapeutic Approaches in the Writings of Isaac Israeli," in Isaac Israeli: The Philosopher Physician, eds. K. Collins, S. Kottek, and H. Paavilainen (Jerusalem, 2015), pp. 139-171.